CN Patent

CN101022791B — 含奈必洛尔的组合物

Assigned to Mylan Inc · Expires 2011-11-16 · 15y expired

What this patent protects

奈必洛尔已经表现出在心血管疾病如高血压、充血性心力衰竭、动脉硬化和内皮功能障碍的治疗中是有益的。本发明特别描述了一种药物组合物，包含奈必洛尔和至少一种其他的活性剂，其中至少一种其他的活性剂是心血管药。

USPTO Abstract

奈必洛尔已经表现出在心血管疾病如高血压、充血性心力衰竭、动脉硬化和内皮功能障碍的治疗中是有益的。本发明特别描述了一种药物组合物，包含奈必洛尔和至少一种其他的活性剂，其中至少一种其他的活性剂是心血管药。

Drugs covered by this patent

Patent Metadata

Patent number: CN101022791B
Jurisdiction: CN
Classification: —
Expires: 2011-11-16
Drug substance claim: No
Drug product claim: No
Assignee: Mylan Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.